دورية أكاديمية
Appropriate Use of Telehealth Visits in Endocrinology: Policy Perspective of the Endocrine Society.
| العنوان: | Appropriate Use of Telehealth Visits in Endocrinology: Policy Perspective of the Endocrine Society. |
|---|---|
| المؤلفون: | Vimalananda VG; Center for Healthcare Organization and Implementation Research, VA Bedford Healthcare System, Bedford, Massachusetts 01730, USA.; Section of Endocrinology, Diabetes, Nutrition & Weight Management, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts, USA., Brito JP; Knowledge and Evaluation Research (KER) Unit, Mayo Clinic, Rochester, Minnesota, USA.; Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Eiland LA; Division of Diabetes, Endocrinology & Metabolism, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA., Lal RA; Division of Endocrinology, Department of Medicine, Stanford University, Stanford, California, USA.; Division of Endocrinology, Department of Pediatrics, Stanford University, Stanford, California, USA.; Stanford Diabetes Research Center, Stanford University, Stanford, California, USA., Maraka S; Knowledge and Evaluation Research (KER) Unit, Mayo Clinic, Rochester, Minnesota, USA.; Division of Endocrinology and Metabolism, Department of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.; Section of Endocrinology, Central Arkansas Veterans Healthcare System, Little Rock, Arkansas, USA., McDonnell ME; Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Narla RR; Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington, Seattle, Washington, USA.; VA Puget Sound Health Care System, Seattle, Washington, USA., Roth MY; Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, University of Washington, Seattle, Washington, USA., Crossen SS; Division of Endocrinology, Department of Pediatrics, University of California Davis School of Medicine, Sacramento, California, USA.; Center for Health and Technology, University of California Davis Health, Sacramento, California, USA. |
| المصدر: | The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2022 Nov 23; Vol. 107 (11), pp. 2953-2962. |
| نوع المنشور: | Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| اللغة: | English |
| بيانات الدورية: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Internet ISSN: 1945-7197 (Electronic) Linking ISSN: 0021972X NLM ISO Abbreviation: J Clin Endocrinol Metab Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: 2017- : New York : Oxford University Press Original Publication: Springfield, Ill. : Charles C. Thomas |
| مواضيع طبية MeSH: | Telemedicine* , Endocrinology*, Humans ; Evidence-Based Medicine ; Ambulatory Care ; Policy |
| مستخلص: | Objective: This work aims to guide clinicians practicing endocrinology in the use of telehealth (synchronous patient-clinician visits conducted over video or telephone) for outpatient care. Participants: The Endocrine Society convened a 9-member panel of US endocrinologists with expertise in telehealth clinical care, telehealth operations, patient-centered care, health care delivery research, and/or evidence-based medicine. Evidence: The panel conducted a literature search to identify studies published since 2000 about telehealth in endocrinology. One member extracted a list of factors affecting the quality of endocrine care via telehealth from the extant literature. The panel grouped these factors into 5 domains: clinical, patient, patient-clinician relationship, clinician, and health care setting and technology. Consensus Process: For each domain, 2 or 3 members drew on existing literature and their expert opinions to draft a section examining the effect of the domain's component factors on the appropriateness of telehealth use within endocrine practice. Appropriateness was evaluated in the context of the 6 Institute of Medicine aims for health care quality: patient-centeredness, equity, safety, effectiveness, timeliness, and efficiency. The panel held monthly virtual meetings to discuss and revise each domain. Two members wrote the remaining sections and integrated them with the domains to create the full policy perspective, which was reviewed and revised by all members. Conclusions: Telehealth has become a common care modality within endocrinology. This policy perspective summarizes the factors determining telehealth appropriateness in various patient care scenarios. Strategies to increase the quality of telehealth care are offered. More research is needed to develop a robust evidence base for future guideline development. (Published by Oxford University Press on behalf of the Endocrine Society 2022.) |
| References: | Clin Diabetes. 2021 Jan;39(1):124-127. (PMID: 33551564) JCO Oncol Pract. 2021 Sep;17(9):546-564. (PMID: 34319760) Diabetes Res Clin Pract. 2016 Jun;116:136-48. (PMID: 27321329) J Med Internet Res. 2015 Jul 21;17(7):e178. (PMID: 26199142) Am J Prev Med. 2021 Sep;61(3):434-438. (PMID: 33781622) Diabetes Care. 2022 Feb 1;45(2):e34-e36. (PMID: 35020822) J Med Internet Res. 2021 Dec 7;23(12):e28503. (PMID: 34878986) J Am Med Inform Assoc. 2009 Jul-Aug;16(4):446-56. (PMID: 19390093) Diabetes Technol Ther. 2020 Jun;22(6):449-453. (PMID: 32383989) Medicine (Baltimore). 2014 Dec;93(28):e312. (PMID: 25526482) J Gen Intern Med. 2022 Apr;37(5):1191-1197. (PMID: 35112280) J Clin Endocrinol Metab. 2022 Apr 19;107(5):1205-1215. (PMID: 35026013) Endocrines. 2021 Dec;2(4):449-456. (PMID: 35373189) J Telemed Telecare. 2023 Feb;29(2):126-132. (PMID: 33226895) Psychiatr Q. 2022 Jun;93(2):689-699. (PMID: 35412100) Nutr Clin Pract. 2021 Aug;36(4):769-774. (PMID: 34156725) Patient Prefer Adherence. 2021 Feb 10;15:283-298. (PMID: 33603347) Telemed J E Health. 2019 Jul;25(7):569-583. (PMID: 30124394) J Gen Intern Med. 2021 Jan;36(1):256-258. (PMID: 33105000) J Med Internet Res. 2020 Dec 1;22(12):e24087. (PMID: 33147166) Diabetes Technol Ther. 2020 Dec;22(12):920-928. (PMID: 32191141) J Med Internet Res. 2018 Nov 05;20(11):e288. (PMID: 30401661) Diabetes Technol Ther. 2018 May;20(5):370-379. (PMID: 29672162) Am J Med Qual. 1999 Jan-Feb;14(1):21-7. (PMID: 10446660) Diabetes Technol Ther. 2018 Dec;20(12):806-816. (PMID: 30461307) Endocr Pract. 2020 Aug;26(8):846-856. (PMID: 33471676) Popul Health Manag. 2021 Dec;24(6):699-700. (PMID: 34000211) Lancet. 2001 Mar 10;357(9258):757-62. (PMID: 11253970) MMWR Morb Mortal Wkly Rep. 2021 Feb 19;70(7):240-244. (PMID: 33600385) J Clin Endocrinol Metab. 2014 Sep;99(9):3112-21. (PMID: 24940655) J Med Internet Res. 2020 Sep 9;22(9):e20786. (PMID: 32810841) JAMA Health Forum. 2020 Jun 1;1(6):e200734. (PMID: 36218529) JAMA. 2021 Mar 16;325(11):1106-1107. (PMID: 33528494) Cochrane Database Syst Rev. 2015 Sep 07;(9):CD002098. (PMID: 26343551) J Endocr Soc. 2017 Nov 06;1(12):1428-1434. (PMID: 29264466) Health Aff (Millwood). 2021 Feb;40(2):349-358. (PMID: 33523745) Soc Sci Med. 1995 Apr;40(7):903-18. (PMID: 7792630) Curr Diab Rep. 2018 May 24;18(7):42. (PMID: 29797292) Curr Diab Rep. 2016 Oct;16(10):96. (PMID: 27549110) Annu Rev Public Health. 2021 Apr 1;42:463-481. (PMID: 33798406) Int J Nurs Stud Adv. 2020 Nov;2:100008. (PMID: 33083791) J Med Internet Res. 2016 Nov 09;18(11):e290. (PMID: 27829574) Intern Med J. 2022 Mar;52(3):451-457. (PMID: 33156576) Telemed J E Health. 2021 Nov;27(11):1225-1234. (PMID: 33513045) JAMA Intern Med. 2022 Jun 1;182(6):680-682. (PMID: 35404417) JAMA Intern Med. 2020 Oct 1;180(10):1386-1389. (PMID: 32744601) JAMA Netw Open. 2020 Dec 1;3(12):e2031640. (PMID: 33372974) J Diabetes Sci Technol. 2021 Sep;15(5):986-992. (PMID: 33719622) Lancet Digit Health. 2022 Jul;4(7):e480-e481. (PMID: 35750399) J Pediatr. 2021 Jun;233:4-7. (PMID: 33137317) J Med Internet Res. 2021 Feb 19;23(2):e23244. (PMID: 33605889) Cochrane Database Syst Rev. 2017 Apr 12;4:CD001431. (PMID: 28402085) Diabetes Technol Ther. 2016 Jan;18(1):7-14. (PMID: 26295939) CMAJ. 2017 Mar 6;189(9):E341-E364. (PMID: 27799615) Med Care Res Rev. 2013 Aug;70(4):351-79. (PMID: 23169897) J Am Board Fam Med. 2021 Nov-Dec;34(6):1103-1114. (PMID: 34772766) |
| معلومات مُعتمدة: | K23 DK122017 United States DK NIDDK NIH HHS; K23 DK125671 United States DK NIDDK NIH HHS; Lilly, Inc.; R37 CA272473 United States CA NCI NIH HHS |
| فهرسة مساهمة: | Keywords: consensus statement; endocrinology; guidelines; policy perspective; telehealth; telemedicine; virtual care |
| تواريخ الأحداث: | Date Created: 20221004 Date Completed: 20221124 Latest Revision: 20230603 |
| رمز التحديث: | 20230603 |
| مُعرف محوري في PubMed: | PMC10233476 |
| DOI: | 10.1210/clinem/dgac494 |
| PMID: | 36194041 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1945-7197 |
|---|---|
| DOI: | 10.1210/clinem/dgac494 |